Congratulations to Dr. Tony Pawson
, Distinguished Scientist at Mount Sinai’s Samuel Lunenfeld Research Institute, who was awarded the 2013 Distinguished Researcher Award today from the Canadian National Proteomics Network.
This prize recognizes remarkable achievements regarding the fundamental understanding and practice of proteomics in biological sciences. Proteomics, the study of a full set of proteins in a particular cell, is vital for our understanding of biological processes, since it is proteins that actually do most of the work that allows cells to function. As most diseases arise due to the aberrant activities of proteins, and since virtually all the drugs we have are either proteins themselves, or act on proteins, understanding how these molecules work is of deep medical significance.
Dr. Pawson is an international leader in proteomics, recognized for his pioneering work on the mechanisms that underlie intracellular signal transduction. He has revolutionized our understanding of the way our cells work in health and in disease. His discoveries contribute to every aspect of medical research and have relevance for the understanding and treatment of a host of diseases including cancer, diabetes, and disorders of the immune system. Dr. Pawson has also played an essential role in powering the successful wave of proteomics research and in nurturing the many outstanding proteomics scientists in Canada.
The Canadian National Proteomics Network (CNPN)
is a not-for-profit, federally incorporated organization created to provide a co-operative mechanism for building the proteomics research infrastructure in Canada and to further a better understanding of proteomics in the Canadian life-sciences community.